CClinicalTrials.gg
Status unknownNCT00446914Updated Aug 19, 2008

High Blood Pressure Strategy (HBPS)

An interventional study of Systems Change (High Blood Pressure Strategy) in Hypertension, sponsored by Heart and Stroke Foundation of Ontario. Status unknown at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2008-08-19.

Sponsored by Heart and Stroke Foundation of Ontario · Not applicable and Interventional

The sponsor has not verified this record recently (last verified Aug 2008), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
5,000
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This program developed by the HSFO aims at helping people of Ontario and their primary healthcare providers better diagnose, manage and control high blood pressure. The High Blood Pressure Strategy brings together healthcare providers and patients to improve the way in which family doctors, nurse practitioners and pharmacists work together and with patients towards improved control of high blood pressure through the use of evidence-informed tools combined with local systems change.

Read the detailed description

Approximately 5,000 patients will participate in the study at 11 family practice sites throughout Ontario. Each of the 11 clinic sites will be randomised to either intervention or delayed intervention 9 months later. The intervention is a systems change involving interprofessional education and management tools to bring together physicians, nurses and pharmacists with the patient. Patients will be monitored by their family doctor or nurse practitioner at scheduled follow-up visits during a period of 36 months for an effect of the intervention over time on the patient's blood pressure.

02

Conditions studied

  • Hypertension

Browse trials for

Keywords

  • Hypertension
  • Blood Pressure
03

In context

Hypertension

6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.

This study's planned enrollment of 5,000 is above the median of 90 across 4,995 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

This is the only study on the registry with Heart and Stroke Foundation of Ontario as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults aged 18 years or older
  • History of elevated BP reading or primary hypertension diagnosis

Exclusion criteria

Exclusion Criteria:

  • Major mental health illness of cognitive impairment
  • Language barrier (unable to speak or read English)
  • Lives in a long-term care home
  • Secondary hypertension
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
5,000 participants (estimated)

Interventions

  • BehavioralSystems Change (High Blood Pressure Strategy)
06

What researchers measure

Primary outcomes

  1. Blood Pressure

    Time frame: 36 months

07

Study locations

1 of 1 sites recruiting
  • Heart and Stroke Foundation of Ontario
    Toronto, Ontario M4P1E4, Canada
    Recruiting
08

References and documents

Publications

  • Tobe SW, Moy Lum-Kwong M, Perkins N, Von Sychowski S, Sebaldt RJ, Kiss A. Heart and Stroke Foundation of Ontario (HSFO) high blood pressure strategy's hypertension management initiative study protocol. BMC Health Serv Res. 2008 Dec 10;8:251. doi: 10.1186/1472-6963-8-251. PubMed 19068141 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 19, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00446914
Lead sponsor
Heart and Stroke Foundation of Ontario
Collaborators
Sunnybrook Health Sciences Centre
First posted
Mar 13, 2007
Start date
Jan 2007
Primary completion
Jan 2010 (estimated)
Completion
Jan 2010 (estimated)
Last update
Aug 19, 2008

Study contacts

Sheldon W Tobe, MD, FRCP(C)
Contact
sheldon.tobe@sunnybrook.ca
416-480-6901
Sheldon W Tobe, MD, FRCP(C)
principal investigator · Sunnybrook Health Sciences Centre
Margaret Moy Lum-Kwong, BSc.N., MBA, CHE
principal investigator · Heart and Stroke Foundation of Ontario
Shirley Von Sychowski, BA, MA
principal investigator · Heart and Stroke Foundation of Ontario
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion